Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines-Reference-Cited by-同舟云学术

Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines

Published:2013-04-15 Issue:10 Volume:190 Page:5065-5077
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Chen Hsin-Wei,Chen Hsin-Yu,Wang Li-Tzu,Wang Fu-Hui,Fang Li-Wen,Lai Hsiu-Yu,Chen Hsuan-Hsu,Lu Jean,Hung Ming-Shiu,Cheng Yao,Chen Mei-Yu,Liu Shih-Jen,Chong Pele,Lee Oscar Kuang-Sheng,Hsu Shu-Ching

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. HETEROTOPIC TRANSPLANTS OF BONE MARROW

2. Mesenchymal Stromal Cells

3. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma

4. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties

5. Mesenchymal stem cells as immunomodulators after liver transplantation

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application;Pathology - Research and Practice;2024-08

2. Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies;Cells;2024-07-28

3. Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC;International Journal of Hematology;2024-07-12

4. CXCL3: A key player in tumor microenvironment and inflammatory diseases;Life Sciences;2024-07

5. Single-cell transcriptomics unveil a unique molecular profile of mesenchymal stem/stromal cell-induced myeloid-derived immune suppressor cells;Molecular Therapy;2024-06